Last reviewed · How we verify
Mentor Purified Toxin
Mentor Purified Toxin is a botulinum toxin preparation that blocks acetylcholine release at the neuromuscular junction by cleaving SNARE proteins.
Mentor Purified Toxin is a botulinum toxin preparation that blocks acetylcholine release at the neuromuscular junction by cleaving SNARE proteins. Used for Facial wrinkles and dynamic expression lines (cosmetic indication), Cervical dystonia, blepharospasm, and other movement disorders (medical indication).
At a glance
| Generic name | Mentor Purified Toxin |
|---|---|
| Also known as | Arms: 1, Other Names:, Mentor Purified Toxin Botulinum Toxin Type A, Botulinum Toxin Type A, Botulinum Toxin |
| Sponsor | Mentor Worldwide, LLC |
| Drug class | Botulinum toxin |
| Target | SNARE complex (synaptobrevin, SNAP-25, syntaxin) |
| Modality | Small molecule |
| Therapeutic area | Aesthetics / Neurology |
| Phase | Phase 3 |
Mechanism of action
Botulinum toxin is a neurotoxin that irreversibly cleaves proteins required for acetylcholine vesicle fusion and release at the neuromuscular junction. This results in temporary paralysis of muscles at the injection site. Mentor Worldwide's purified formulation is designed to minimize immunogenicity while maintaining therapeutic efficacy for cosmetic and medical applications.
Approved indications
- Facial wrinkles and dynamic expression lines (cosmetic indication)
- Cervical dystonia, blepharospasm, and other movement disorders (medical indication)
Common side effects
- Injection site pain or bruising
- Headache
- Muscle weakness or paralysis (off-target)
- Antibody formation (immunogenicity)
Key clinical trials
- PurTox (Botulinum Toxin Type A) for the Treatment of Adult Onset Spasmodic Torticollis/Cervical Dystonia (PHASE1)
- Safety and Efficacy Study of PurTox® Botulinum Toxin Type A to Treat Frown Lines Between the Eyebrows (PHASE3)
- Safety and Efficacy Study of Repeat Treatment With PurTox® Botulinum Toxin Type A for Frown Lines Between the Eyebrows (PHASE3)
- A Long-Term Safety Study of Repeat Treatment With PurTox® for Frown Lines Between the Eyebrows (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |